Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.

David R AndersonMichael DunbarJohn MurnaghanSusan R KahnPeter GrossMichael ForsytheStephane PeletWilliam FisherEtienne BelzileSean DolanMark CrowtherEric BohmSteven J MacDonaldWade GoftonPaul KimDavid ZukorSusan PleasancePantelis AndreouSteve Paul DoucetteChris TheriaultAbongnwen AbianuiMarc CarrierMichael J KovacsMarc A RodgerDoug CoylePhilip S WellsPascal-Andre Vendittoli

Published in: The New England journal of medicine (2018)

Among patients who received 5 days of rivaroxaban prophylaxis after total hip or total knee arthroplasty, extended prophylaxis with aspirin was not significantly different from rivaroxaban in the prevention of symptomatic venous thromboembolism. (Funded by the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT01720108 .).

Keyphrases

venous thromboembolism
total knee arthroplasty
total hip
direct oral anticoagulants
low dose
cardiovascular events
antiplatelet therapy
atrial fibrillation
type diabetes
cardiovascular disease
coronary artery disease
total hip arthroplasty